Peripheral Blood Stem Cell Transplantation clinical trials

Explore recruiting peripheral blood stem cell transplantation clinical trials.

Recruiting peripheral blood stem cell transplantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Peripheral Blood Stem Cell Transplantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase II multicenter study of carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy, followed by high-dose therapy with melphalan and autologous peripheral blood stem cell transplantation, consolidation with KRd, and maintenance with lenalidomide and dexamethasone in patients ≤ 70 years old with smoldering multiple myeloma (SMM) with high risk of progression to symptomatic myeloma

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label, randomized, non-comparative multi-center phase I/II study to assess the safety and the efficacy of SMART101 after HLA-mismatched peripheral blood stem cell transplantation with post-transplant cyclophosphamide in patients with hematological malignancies

Italy, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Graft vs Host Disease Prophylaxis in unrelated donor transplantation: a randomized clinical trial comparing PTCY vs ATG

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Peripheral Blood Stem Cell Transplantation trials by city

Peripheral Blood Stem Cell Transplantation in Toronto Peripheral Blood Stem Cell Transplantation in Vancouver Peripheral Blood Stem Cell Transplantation in Montreal Peripheral Blood Stem Cell Transplantation in Calgary Peripheral Blood Stem Cell Transplantation in Edmonton Peripheral Blood Stem Cell Transplantation in Ottawa Peripheral Blood Stem Cell Transplantation in Winnipeg Peripheral Blood Stem Cell Transplantation in Quebec City Peripheral Blood Stem Cell Transplantation in Hamilton Peripheral Blood Stem Cell Transplantation in Kitchener Peripheral Blood Stem Cell Transplantation in London Peripheral Blood Stem Cell Transplantation in Halifax Peripheral Blood Stem Cell Transplantation in New York Peripheral Blood Stem Cell Transplantation in Los Angeles Peripheral Blood Stem Cell Transplantation in Chicago Peripheral Blood Stem Cell Transplantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease